EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, CABA: Cabaletta Bio Inc

08 Dec 25 17:30
LAST:

2.480

CHANGE:
 0.07		OPEN:
2.580		HIGH:
2.680		ASK:
0.000		VOLUME:
2.5M
CHG(%):
2.75		PREV:
2.550		LOW:
2.480		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
08 Dec 252.5802.6802.4802.4802.5M
05 Dec 252.5702.7002.5152.5502.23M
04 Dec 252.4802.6302.4502.5602.42M
03 Dec 252.3402.5602.3202.5003.3M
02 Dec 252.4502.4782.3252.3403.06M
01 Dec 252.5002.5052.4002.4301.58M
28 Nov 252.3802.6902.3402.5702.61M
26 Nov 252.2202.4502.1802.3703.15M
25 Nov 252.2352.2802.1152.2001.96M
24 Nov 252.1002.3102.0702.3002.22M

PROFILE

Name:Cabaletta Bio Inc
About:Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases. Its lead product candidate is resecabtagene autoleucel, a 4-1BB co-stimulatory domain-containing fully human CD19-CAR T, which is in Phase 1/2 clinical trials for the treatment of dermatomyositis, anti-synthetase syndrome, immune-mediated necrotizing myopathy, juvenile myositis, lupus nephritis, non-renal systemic lupus erythematosus, relapsing and progressive multiple sclerosis, mucocutaneous and mucosal pemphigus vulgaris (PV), systemic sclerosis, and generalized myasthenia gravis. The company also develops DSG3-CAART, a CAAR T cell therapy that is in Phase 1 clinical trial for the treatment of mucosal PV; and MuSK-CAART, an investigational cell therapy in Phase 1 trial for treating patients with anti-muscle-specific kinase (MuSK) antibody positive myasthenia gravis. It has collaborations with the University of Pennsylvania and the Children's Hospital of Philadelphia; Nanjing IASO Biotherapeutics Co., Ltd; Oxford Biomedica; Autolus Holdings (UK) Limited; and WuXi Advanced Therapies, Inc. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.
Sector:Healthcare
Industry:Biotechnology
Address:2929 Arch Street, Philadelphia, PA, United States, 19104
Website:https://www.cabalettabio.com
CUSIP:12674W109
CIK:0001759138
ISIN:US12674W1099
FIGI:BBG00MJ3BKW2

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-1.29 
Forward P/E:-1.50 
PEG Ratio:-0.04 
Price to Book:1.85 
Return on Assets:-0.42 
Return on Equity:-0.76 
EPS Ratio:-2.71 
Shares:91.47M 
Market Cap:226.83M 

TECHNICAL INDICATORS

MA5:2.490.2%
MA10:2.432.1%
MA20:2.384.4%
MA50:2.521.8%
MA100:2.1217.2%
MA200:1.8732.9%
STO9:56.00
STO14:64.52
RSI14:52.94
WPR14:-18.37 
MTM14:0.14
ROC14:0.06 
ATR:0.21 
Week High:2.708.9%
Week Low:2.326.9%
Month High:2.708.9%
Month Low:2.0132.9%
Year High:3.6748.0%
Year Low:0.99150.5%
Volatility:162.14